ARALEZ PHARMACEUTICALS INC - COM (ARLZ)

CUSIP: 03852X100

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
12,927,724
Share change
-2,847,730
Total reported value
$29,598,654
Put/Call ratio
125%
Price per share
$2.29
Number of holders
50
Value change
-$3,807,629
Number of buys
20
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q3 2017

As of 30 Sep 2017, ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,927,724 shares. The largest 10 holders included PAR CAPITAL MANAGEMENT INC, DEERFIELD MANAGEMENT CO, BlackRock Inc., DEUTSCHE BANK AG\, GSA CAPITAL PARTNERS LLP, DIMENSIONAL FUND ADVISORS LP, JW Asset Management, LLC, WELLS FARGO & COMPANY/MN, Contrarius Investment Management Ltd, and Brown Advisory Securities, LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.